| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.916004 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221216104152 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 221006t20222022onc o f000 0 eng d |
|---|
| 020 | |a9780660457413 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-416/2022E-PDF |
|---|
| 245 | 00|aCOVID-19 vaccines mass campaign : |bconcept testing. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2022. |
|---|
| 264 | 4|c©2022 |
|---|
| 300 | |a1 online resource (153 pages) + |e1 executive summary (15 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Campagne de masse pour les vaccins COVID-19 : test de concept. |
|---|
| 500 | |a"September 2022." |
|---|
| 500 | |a"Contract #: HT372-204504/001/CY." |
|---|
| 500 | |a"POR Number: 118-20." |
|---|
| 650 | 0|aCOVID-19 (Disease)|xVaccination|xGovernment policy|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 710 | 2 |aQuorus Consulting Group, |econsultant. |
|---|
| 775 | 08|tCampagne de masse pour les vaccins COVID-19 : |w(CaOODSP)9.916005 |
|---|
| 856 | 40|qPDF|s12.40 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H14-416-2022-eng.pdf|zFinal Report |
|---|
| 856 | 40|qPDF|s761 KB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H14-416-2022-1-eng.pdf|zExecutive Summary |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/118-20-e/POR118-20-Report.html|zFinal Report |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/118-20-e/summary/POR118-20-Summary.html|zExecutive Summary |
|---|